Definium Therapeutics, Inc.
DFTX· Nasdaq
Definium Therapeutics, Inc.
- Last sale
- Oct 2, 2026 · -0.57%
- Market cap
- $5.03B
- 134.37M shares
- Filings
- 503
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Net Interest Income
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2023 | 2023-12-31 | $4,664,000 | reported | |
| FY 2022 | 2022-12-31 | $1,495,000 | reported | |
| FY 2021 | 2021-12-31 | $359,000 | reported | |
| FY 2020 | 2020-12-31 | $164,000 | reported |
Definium Therapeutics, Inc. · CIK 1813814 · Engraved from SEC EDGAR
